Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 11, 2019 - Issue
Submit an article Journal homepage
134
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Cost–benefit comparison of liraglutide and sitagliptin in the treatment of type 2 diabetes in Thailand

Chaicharn Deerochanawong1 Rajavithi Hospital, College of Medicine, Rangsit University, Ministry of Public Health, Bangkok10400, Thailand
,
Natapong Kosachunhanun2 Department of Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai50200, Thailand
,
Arvind V Gadekar3 Novo Nordisk Pharma (Thailand) Ltd., Bangkok10500, Thailand
,
Pitthaporn Chotikanokrat3 Novo Nordisk Pharma (Thailand) Ltd., Bangkok10500, Thailand
&
Unchalee Permsuwan4 Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai50200, ThailandCorrespondence[email protected]
Pages 423-430 | Published online: 11 Jul 2019

References

  • Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. 2011;34(6):1249–1257. doi:10.2337/dc11-044221617109
  • Papier K, Jordan S, D‘Este C, et al. Incidence and risk factors for type 2 diabetes mellitus in transitional Thailand: results from the Thai cohort study. BMJ Open. 2016;6(12):e014102. doi:10.1136/bmjopen-2016-014102
  • Aekplakorn W, Puckcharern H, Thaikla K, Satheannoppakao W. Thai National Health Examination Survey V. Bangkok: Health Systems Research Institute; 2014.
  • Strategy and Planning Division, Ministry of Public Health. Public Health Statistics. A.D.2016 Bangkok:  Ministry of Public Health; 2017.
  • Deerochanawong C, Ferrario A. Diabetes management in Thailand: a literature review of the burden, costs, and outcomes. Global Health. 2013;9:11. doi:10.1186/1744-8603-9-1123497447
  • Brouwer WB, Rutten FF, Koopmanschap MA. Costing in economic evaluations In: Drummond M, McGuire A, editors. Economic Evaluation in Health Care: Merging Theory with Practice. New York: Oxford University Press; 2001:68–93.
  • Chatterjee S, Riewpaiboon A, Piyauthakit P, et al. Cost of diabetes and its complications in Thailand: a complete picture of economic burden. Health Soc Care Community. 2011;19(3):289–298. doi:10.1111/j.1365-2524.2010.00981.x21276105
  • Pratley RE. Overview of glucagon-like peptide-1 analogs and dipeptidyl peptidase-4 inhibitors for type 2 diabetes. Medscape J Med. 2008;10(7):171.18769687
  • Pratley RE, Nauck M, Bailey T, et al. Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial. Lancet (London, England). 2010;375(9724):1447–1456. doi:10.1016/S0140-6736(10)60307-8
  • Pratley R, Nauck M, Bailey T, et al. One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial. Int J Clin Pract. 2011;65(4):397–407. doi:10.1111/j.1742-1241.2011.02656.x21355967
  • Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375(4):311–322. doi:10.1056/NEJMoa160382727295427
  • Singh AK, Singh R. Recent cardiovascular outcome trials of antidiabetic drugs: a comparative analysis. Indian J Endocrinol Metab. 2017;21(1):4–10. doi:10.4103/2230-8210.19602628217490
  • Green JB, Bethel MA, Armstrong PW, et al. Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015;373(3):232–242. doi:10.1056/NEJMoa150135226052984
  • National Drug System Development Committee. Median Drug Price Annoucement. Bangkok: Office of the Prime Minister Bangkok: Royal Gazette in Thailand; 2018.
  • Anukoolsawat P, Sritara P, Teerawattananon Y. Costs of lifetime treatment of acure coronary syndrome at Ramathibodi hospital. Thai Heart J. 2006;19:132–143.
  • Khiaocharoen O, Pannarunothai S, Zungsontiporn C. Cost of acute and sub-acute care for stroke patients. J Med Assoc Thai. 2012;95(10):1266–1277.23193739
  • Bank of Thailand. Foreign Exchange Rate 2018. Available from: https://www.bot.or.th/English/FinancialMarkets/layouts/Application/ExchangeRate/ExchangeRate.aspx. Accessed September 24, 2018.
  • Skovgaard R, Jon Ploug U, Hunt B, Valentine WJ. Evaluating the cost of bringing people with type 2 diabetes mellitus to multiple targets of treatment in Canada. Clin Ther. 2015;37(8):1677–1688. doi:10.1016/j.clinthera.2015.05.49626186809
  • Zheng SL, Roddick AJ, Aghar-Jaffar R, et al. Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: a systematic review and meta-analysis. Jama. 2018;319(15):1580–1591. doi:10.1001/jama.2018.302429677303
  • Mann JFE, Orsted DD, Brown-Frandsen K, et al. Liraglutide and renal outcomes in type 2 diabetes. N Engl J Med. 2017;377(9):839–848. doi:10.1056/NEJMoa161601128854085
  • de Wit HM, Vervoort GM, Jansen HJ, de Grauw WJ, de Galan BE, Tack CJ. Liraglutide reverses pronounced insulin-associated weight gain, improves glycaemic control and decreases insulin dose in patients with type 2 diabetes: a 26 week, randomised clinical trial (ELEGANT). Diabetologia. 2014;57(9):1812–1819. doi:10.1007/s00125-014-3302-024947583
  • de Wit HM, Vervoort GM, Jansen HJ, de Galan BE, Tack CJ. Durable efficacy of liraglutide in patients with type 2 diabetes and pronounced insulin-associated weight gain: 52-week results from the effect of liraglutide on insulin-associated wEight GAiN in patients with type 2 diabetes’ (ELEGANT)randomized controlled trial. J Intern Med. 2016;279(3):283–292. doi:10.1111/joim.1244726553486

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.